Bio-Techne Corporation (TECH) News
Follow Bio-Techne Corporation (TECH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 32 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Tech earnings prompt ‘sober questions’
Some investors are dialing back their expectations for US economic growth, as warning signs flashed red over the sustainability of the country’s breakneck AI buildout. The tech-heavy Nasdaq slid into correction territory
EARNINGS | Nov 01, 2026, 10:28 PM UTC
M
Techstep Launches Rights Issue at NOK 1 Per Share
Techstep ASA plans a rights issue at NOK 1 per share to raise NOK 83.3–100 million.
EQUITY | Oct 15, 2026, 04:03 PM UTC
L
Techstep Awarded Contract In Sweden
Techstep ASA OSL:TECH
NEWS | Sep 25, 2026, 07:42 AM UTC
L
Bio-Techne Continues to Expect Transaction to Close by Late 2026 or Early 2027 >TECH
Bio-Techne Continues to Expect Transaction to Close by Late 2026 or Early 2027 >TECH
NEWS | Sep 23, 2026, 01:22 PM UTC
L
Bio-Techne: Waiting Period Under Hart-Scott-Rodino Antitrust Act Expired >TECH
Bio-Techne: Waiting Period Under Hart-Scott-Rodino Antitrust Act Expired >TECH
NEWS | Sep 23, 2026, 01:21 PM UTC
H
Bio-Techne Corporation (TECH) Holders Approve Acquisition by Merck KGaA
Bio-Techne shareholders approved the Merger Agreement for its acquisition by Merck KGaA, Darmstadt, Germany. HSR waiting period expired Sept. 18, 2026; closing expected by late 2026 or early 2027, subject to remaining re
MNA | Sep 23, 2026, 01:21 PM UTC
L
Bio-Techne Hldrs Approve Acquisition by Merck KGaA, Darmstadt, Germany
Bio-Techne Hldrs Approve Acquisition by Merck KGaA, Darmstadt, Germany
MNA | Sep 23, 2026, 01:20 PM UTC
L
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MINNEAPOLIS, Sept. 23, 2026 // -- Bio-Techne Corporation (NASDAQ:TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve an
MNA | Sep 23, 2026, 01:20 PM UTC
L
TECH - Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
TECH - Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
MNA | Sep 23, 2026, 01:20 PM UTC
L
TECH - Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
TECH - Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
NEWS | Sep 22, 2026, 01:03 PM UTC
L
Bio-Techne supplements proxy disclosures after shareholder suit, seeks shareholder vote on Sept. 23
Bio-Techne supplemented its proxy statement and disclosed litigation and demand letters tied to the Merck KGaA acquisition while preserving the Sept. 23 shareholder vote.Key Highlights:Original SEC Filing: BIO-TECHNE Cor
MNA | Sep 14, 2026, 09:14 PM UTC
L
Bio-Techne achieves Science Based Targets validation
Bio-Techne achieved Science Based Targets validation and reported progress toward climate goals.
EQUITY | Sep 01, 2026, 10:30 AM UTC
L
Bio-Techne validates science-based targets and cites climate progress
Bio-Techne (TECH) announced validation of its science-based targets and reported significant progress toward its climate goals in its Fiscal 2026 highlights.
EQUITY | Sep 01, 2026, 10:30 AM UTC
L
Techstep unit recommended as sole supplier in procurement process
Techstep ASA unit has been recommended for award as the sole supplier in a procurement process.
EQUITY | Sep 01, 2026, 10:26 AM UTC
L
Techstep appoints Håvard Haukdal as permanent CFO
Techstep has appointed Håvard Haukdal as its permanent CFO.
EQUITY | Sep 01, 2026, 05:01 AM UTC
H
Nvidia-led earnings lift US tech indices, S&P 500 and Nasdaq 100 up
US equity indices gained traction on Thursday as Nvidia surged after strong results and a 70% revenue forecast next fiscal year. S&P 500 and Nasdaq 100 rose nearly 1%; Dow added 200 points, while Broadcom and Intel climb
EARNINGS | Aug 27, 2026, 05:01 PM UTC
L
TECH - Bio-Techne Corrects Dividend Announcement
TECH - Bio-Techne Corrects Dividend Announcement
EQUITY | Aug 13, 2026, 10:30 AM UTC
M
Bio-Techne Releases Q4 Fiscal 2026 Results
Bio-Techne releases fourth quarter fiscal 2026 results
EQUITY | Aug 12, 2026, 10:31 AM UTC
L
TECH - Bio-Techne Declares Dividend
TECH - Bio-Techne Declares Dividend
EQUITY | Aug 12, 2026, 10:30 AM UTC
H
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Qiagen NV (NYSE: QGEN ) is drawing renewed investor attention after reports that several private equity firms are evaluating a potential takeover of the molecular diagnostics company. The stock surged 10.5% in the previo
MACRO | Jul 10, 2026, 01:26 PM UTC
L
TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.
EQUITY | Jun 30, 2026, 01:38 PM UTC
L
Benchmark Downgrades Bio-Techne to Hold
Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold.
EQUITY | Jun 30, 2026, 01:18 PM UTC
H
Bio-Techne, Merck KGaA Set Termination Fees
Bio-Techne to pay $230.5M termination fee to Merck KGaA if deal isn't consummated, while Merck KGaA to pay $576.1M if deal is terminated
EQUITY | Jun 26, 2026, 10:12 AM UTC
M
12 Health Care Stocks Move
Multiple health care stocks are moving in Thursday's intraday session, with gainers including Atlantic International and SELLAS Life Sciences, and losers including Nano X Imaging and Passage Bio
EQUITY | Jun 25, 2026, 05:05 PM UTC
H
Merck Buys Bio-Techne
Merck KGaA agrees to acquire Bio-Techne Corporation in an all-cash transaction valued at approximately $11.3 billion
EQUITY | Jun 25, 2026, 01:34 PM UTC
H
US Stocks: Premarket Movers
US stocks are moving premarket, with WYY up 45% and TECH up 19% on acquisition news, while ELME falls 28% on terminated agreement
EQUITY | Jun 25, 2026, 12:53 PM UTC
H
TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 12:04 PM UTC
H
Merck KGaA Acquires Bio-Techne
Merck KGaA to acquire Bio-Techne for $73 per share in cash, representing a total enterprise value of approximately $11.3 billion
EQUITY | Jun 25, 2026, 10:21 AM UTC
H
Merck Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
EQUITY | Jun 25, 2026, 10:11 AM UTC